The Global Voice of Quality.
Bring out the best in your career or organization by joining ASQ with an individual or organizational membership. We've got the membership that's right for you.
What Do You Want To Do?
Golf Ball Pieces from Harvest Cause Hash Brown RecallPosted on April 24, 2017
A food company is recalling frozen hash browns from stores in nine states because the potatoes may have pieces of golf balls... Full Story
Phenobarbital 15 mg Tablets, USP by C.O. Truxton: RecallLabeling Error on Declared StrengthPosted on April 24, 2017
C.O. Truxton, Inc. is voluntarily recalling lot 70952A of Phenobarbital Tablets, USP, 15 mg, to the consumer/user level. The... Full Story
Tesla Recalls 53,000 Model S and X Vehicles for Brake IssuesPosted on April 21, 2017
Electric car maker Tesla (TSLA) is voluntarily recalling 53,000 Model S and X vehicles after recently discovering... Full Story
Company Testing Facebook Chatbot to Communicate with CustomersPosted on April 21, 2017
Wells Fargo and Company is testing a chatbot, an automated program that can communicate with the banks customers on... Full Story
New Battery Coating Could Improve Smart Phones and Electric VehiclesPosted on April 20, 2017
High performing lithium-ion batteries are a key component of laptops, smart phones, and electric vehicles. Currently, the... Full Story
FDA Approves First Drug for Moderate and Severe Eczema CasesPosted on April 20, 2017
U.S. regulators have approved the first powerful, injected medicine to treat serious cases of the skin condition eczema. ... Full Story
Unichem Laboratories Receives ANDA Approval for Piroxicam CapsulesPosted on April 19, 2017
Unichem Laboratories has received ANDA approval from the United States Food and Drug Administration (USFDA) for Piroxicam... Full Story
Subaru Recalls Over 33,000 Vehicles for Engine FailuresPosted on April 19, 2017
The recall covers Impreza cars from the 2017 model year. Subaru is recalling over 33,000 vehicles in the U.S. because of... Full Story
FDA Approves Genentechs Lucentis (Ranibizumab Injection) for Diabetic Retinopathy, the Leading Cause of Blindness Among Working Age Adults in the United StatesPosted on April 18, 2017
Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) approved Lucentis... Full Story
ASQ Hosted Communities
ASQ Social Communities
Share common experiences and challenges around a specific area of interest.
Topics & Industries
Get answers and ideas from ASQ member groups that cover a range of specific industries and topics.
Connect with people in more than 250 locations around the world.